Paper41867752
Comprehensive Mapping of Immune Nanobody Repertoires with NanoMAP.
White WL and 7 others. bioRxiv, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Comprehensive Mapping of Immune Nanobody Repertoires with NanoMAP. Papers, record 41867752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41867752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K12 GM133314 | NIGMS NIH HHS | United States | K12GM133314 | PubMed | NIH RePORTER |
| R01 AI125704 | NIAID NIH HHS | United States | R01AI125704 | PubMed | NIH RePORTER |
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10698934 | Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire. | EMBO J | 2000 | https://conductscience.org/library/papers/10698934 | PubMed |
| 2 | 31894001 | Development of therapeutic antibodies for the treatment of diseases. | J Biomed Sci | 2020 | https://conductscience.org/library/papers/31894001 | PubMed |
| 3 | 29035372 | MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. | Nat Biotechnol | 2017 | https://conductscience.org/library/papers/29035372 | PubMed |
| 4 | 39433212 | Nanobodies: From High-Throughput Identification to Therapeutic Development. | Mol Cell Proteomics | 2024 | https://conductscience.org/library/papers/39433212 | PubMed |
| 5 | 15355155 | Properties of the Hubert-Arabie adjusted Rand index. | Psychol Methods | 2004 | https://conductscience.org/library/papers/15355155 | PubMed |
| 6 | 35563400 | Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35563400 | PubMed |
| 7 | 36798133 | A novel, non-neuronal acetylcholinesterase of schistosome parasites is essential for definitive host infection. | Front Immunol | 2023 | https://conductscience.org/library/papers/36798133 | PubMed |
| 8 | 35803998 | Intramuscular delivery of formulated RNA encoding six linked nanobodies is highly protective for exposures to three Botulinum neurotoxin serotypes. | Sci Rep | 2022 | https://conductscience.org/library/papers/35803998 | PubMed |
| 9 | 26069265 | Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. | Bioinformatics | 2015 | https://conductscience.org/library/papers/26069265 | PubMed |
| 10 | 32574157 | Somatic hypermutation analysis for improved identification of B cell clonal families from next-generation sequencing data. | PLoS Comput Biol | 2020 | https://conductscience.org/library/papers/32574157 | PubMed |
| 11 | 39166870 | Single domain antibody: Development and application in biotechnology and biopharma. | Immunol Rev | 2024 | https://conductscience.org/library/papers/39166870 | PubMed |
| 12 | 41193399 | From discovery to the clinic: structural insights, engineering options, clinical, and 'next wave' applications of camelid-derived single-domain antibodies. | MAbs | 2025 | https://conductscience.org/library/papers/41193399 | PubMed |
| 13 | 34990480 | Probing the structure and function of the protease domain of botulinum neurotoxins using single-domain antibodies. | PLoS Pathog | 2022 | https://conductscience.org/library/papers/34990480 | PubMed |
| 14 | 22238680 | A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model. | PLoS One | 2012 | https://conductscience.org/library/papers/22238680 | PubMed |
| 15 | 27365031 | Antibodies and antibody-derived analytical biosensors. | Essays Biochem | 2016 | https://conductscience.org/library/papers/27365031 | PubMed |
| 16 | 23435259 | Predicting the molecular complexity of sequencing libraries. | Nat Methods | 2013 | https://conductscience.org/library/papers/23435259 | PubMed |
| 17 | 34478129 | Therapeutic Antibodies: An Overview. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/34478129 | PubMed |
| 18 | 28785006 | A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding. | Sci Rep | 2017 | https://conductscience.org/library/papers/28785006 | PubMed |
| 19 | 24618469 | pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24618469 | PubMed |
| 20 | 23813602 | Schistosomiasis chemotherapy. | Angew Chem Int Ed Engl | 2013 | https://conductscience.org/library/papers/23813602 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41867752
GET https://conductscience.org/api/papers/v1/41867752/references?page=2